Vanguard Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.33M | Buy |
8,259,128
+191,575
| +2% | +$216K | ﹤0.01% | 2941 |
|
|
2025
Q1 | $11.8M | Buy |
8,067,553
+66,861
| +0.8% | +$97.6K | ﹤0.01% | 2756 |
|
|
2024
Q4 | $17M | Sell |
8,000,692
-327,007
| -4% | -$697K | ﹤0.01% | 2660 |
|
|
2024
Q3 | $23.3M | Buy |
8,327,699
+132,033
| +2% | +$370K | ﹤0.01% | 2518 |
|
|
2024
Q2 | $19.1M | Sell |
8,195,666
-11,898
| -0.1% | -$27.7K | ﹤0.01% | 2598 |
|
|
2024
Q1 | $36.7M | Sell |
8,207,564
-823,261
| -9% | -$3.68M | ﹤0.01% | 2300 |
|
|
2023
Q4 | $29M | Sell |
9,030,825
-1,556,979
| -15% | -$5M | ﹤0.01% | 2428 |
|
|
2023
Q3 | $33.6M | Buy |
10,587,804
+3,086,311
| +41% | +$9.78M | ﹤0.01% | 2319 |
|
|
2023
Q2 | $37.3M | Buy |
7,501,493
+196,157
| +3% | +$975K | ﹤0.01% | 2320 |
|
|
2023
Q1 | $36.1M | Buy |
7,305,336
+40,115
| +0.6% | +$198K | ﹤0.01% | 2324 |
|
|
2022
Q4 | $45.7M | Buy |
7,265,221
+102,139
| +1% | +$642K | ﹤0.01% | 2224 |
|
|
2022
Q3 | $77.4M | Sell |
7,163,082
-1,243,065
| -15% | -$13.4M | ﹤0.01% | 1950 |
|
|
2022
Q2 | $95.8M | Buy |
8,406,147
+1,652,167
| +24% | +$18.8M | ﹤0.01% | 1850 |
|
|
2022
Q1 | $61.5M | Buy |
6,753,980
+12,141
| +0.2% | +$111K | ﹤0.01% | 2203 |
|
|
2021
Q4 | $101M | Buy |
6,741,839
+46,119
| +0.7% | +$688K | ﹤0.01% | 1981 |
|
|
2021
Q3 | $172M | Buy |
6,695,720
+93,414
| +1% | +$2.4M | ﹤0.01% | 1692 |
|
|
2021
Q2 | $172M | Buy |
6,602,306
+645,613
| +11% | +$16.8M | ﹤0.01% | 1709 |
|
|
2021
Q1 | $210M | Buy |
5,956,693
+170,216
| +3% | +$6.01M | 0.01% | 1552 |
|
|
2020
Q4 | $146M | Buy |
5,786,477
+129,274
| +2% | +$3.26M | ﹤0.01% | 1641 |
|
|
2020
Q3 | $213M | Sell |
5,657,203
-224,111
| -4% | -$8.45M | 0.01% | 1240 |
|
|
2020
Q2 | $252M | Buy |
5,881,314
+1,781,863
| +43% | +$76.3M | 0.01% | 1128 |
|
|
2020
Q1 | $79.7M | Buy |
4,099,451
+151,158
| +4% | +$2.94M | ﹤0.01% | 1656 |
|
|
2019
Q4 | $103M | Buy |
3,948,293
+523
| +0% | +$13.6K | ﹤0.01% | 1738 |
|
|
2019
Q3 | $108M | Buy |
3,947,770
+504,590
| +15% | +$13.8M | ﹤0.01% | 1681 |
|
|
2019
Q2 | $92.4M | Buy |
3,443,180
+1,343,459
| +64% | +$36.1M | ﹤0.01% | 1794 |
|
|
2019
Q1 | $60.7M | Buy |
2,099,721
+53,392
| +3% | +$1.54M | ﹤0.01% | 1997 |
|
|
2018
Q4 | $55.1M | Buy |
+2,046,329
| New | +$55.1M | ﹤0.01% | 1982 |
|